Drug details

Fylnetra (pegfilgrastim-pbbk injection, for subcutaneous use)

type of Hematopoietic Growth Factors

Fylnetra (pegfilgrastim-pbbk) is a leukocyte growth factor indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.

This drug may have the following side effects:

• pain in extremities.
• bone pain and

The following drugs are related to Fylnetra, either as a replacement or used together:

• Ambisome (amphotericin b)
• Augmentin (amoxicillin clavulanate)
• Augmentin ES (amoxicillin clavulanate potassium)
• Augmentin XR (amoxicillin clavulanic potassium)
• Azactam Injection (aztreonam injection)
• Maxipime (cefepime hydrochloride for injection)
• Fortaz (ceftazidime)
• Primaxin I.V. (imipenem and cilastatin for injection)
• Sporanox (itraconazole capsules)
• Tobi (tobramycin)